Braveheart Bio, Inc. Common Stock (BRVE)

Oct 06, 2026

Braveheart Bio, Inc. Common Stock (NASDAQ: BRVE) Stock Price, News & Analysis - Kalkine

Oct 06, 2026

Sep 25, 2026

Braveheart Bio, Inc. (NASDAQ:BRVE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Sep 25, 2026

Sep 24, 2026

Braveheart Bio, Inc. Common Stock (NASDAQ: BRVE) Stock Price, News & Analysis - kalkine.ca

Sep 24, 2026

Sep 10, 2026

OrbiMed's stake in Braveheart Bio (BRVE) falls without selling shares - Stock Titan

Sep 10, 2026

Sep 09, 2026

Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times

Sep 09, 2026

Aug 14, 2026

AH Bio Fund IV Discloses Investment at Braveheart Bio with 11.4% Stake - TradingView

Aug 14, 2026

Aug 10, 2026

Braveheart Bio CFO Acquires 27,777 Shares for $500,000. Is This a Signal BRVE IPO Is a Success? - The Motley Fool

Aug 10, 2026

Aug 10, 2026

Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors? - The Motley Fool

Aug 10, 2026

Aug 10, 2026

Braveheart Bio CEO Travis Murdoch Buys 83,333 Shares for $1.5 Million. Is This a Buy Signal for Investors? - The Motley Fool

Aug 10, 2026

Aug 08, 2026

Braveheart Bio, Inc. Common Stock (BRVE) Stock Price Today: $27.43 - Gotrade

Aug 08, 2026

Aug 07, 2026

Braveheart Bio Announces Closing of Upsized Initial Public - GlobeNewswire

Aug 07, 2026

Aug 07, 2026

Braveheart Bio raises $439.9M in upsized Nasdaq IPO - Investing.com

Aug 07, 2026

Aug 07, 2026

Braveheart Bio closes $439.9 million IPO on Nasdaq - Investing.com

Aug 07, 2026

Aug 07, 2026

Braveheart Bio Insider Bought Shares Worth $499,986, According to a Recent SEC Filing - Yahoo Finance

Aug 07, 2026

Aug 06, 2026

Heart drug developer Braveheart Bio surges on public debut after upsized IPO - Seeking Alpha

Aug 06, 2026

Aug 06, 2026

Braveheart Bio Announces Pricing of Upsized Initial Public Offering - The Manila Times

Aug 06, 2026

Aug 06, 2026

Braveheart Bio Shares Rise After Market Debut - Yahoo Finance

Aug 06, 2026

Aug 06, 2026

Braveheart Bio Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Aug 06, 2026

Aug 06, 2026

Braveheart Bio shares surge 68% in New York trading debut - Investing.com

Aug 06, 2026

Aug 05, 2026

Braveheart Bio (Nasdaq:BRVE)Stock Analysis - Simply Wall Street

Aug 05, 2026

Aug 05, 2026

Braveheart Bio, Inc. (BRVE) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 05, 2026

Aug 05, 2026

Braveheart Bio Expects Nasdaq Debut Aug. 6 After $18 IPO - Stock Titan

Aug 05, 2026

Aug 05, 2026

Braveheart Bio prices IPO at $18 per share, raises $382.5M - Investing.com

Aug 05, 2026

Aug 01, 2026

Braveheart Bio, Inc. IPO Analysis: Financial Outlook, Broker Coverage and Listing Prospects - Minichart

Aug 01, 2026

Jul 31, 2026

Funding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s - Pharmaceutical Executive

Jul 31, 2026

Jul 31, 2026

Braveheart Bio Readies $300 Million IPO Plan (BRVE) - Seeking Alpha

Jul 31, 2026

Jul 30, 2026

Braveheart Bio, Attovia seek $275M and $182M in U.S. IPOs - Seeking Alpha

Jul 30, 2026

Jul 30, 2026

Braveheart Bio seeks $318.8M in IPO for heart drug - Investing.com

Jul 30, 2026